Summary: Traumatic brain injury evokes multiple axonal pa thologies that contribute to the ultimate disconnection of in jured axons, In severe traumatic brain injury, the axolemma is perturbed focally, presumably allowing for the influx of Ca 2 + and initiation of Ca 2 +-sensitive, proaxotomy processes. Mito chondria in foci of axolemmal failure may act as Ca 2 + sinks that sequester Ca 2 + to preserve low cytoplasmic calcium con centrations. This Ca 2 + load within mitochondria, however, may cause colloid osmotic swelling and loss of function by a Ca 2 +_ induced opening of the permeability transition pore. Local fail ure of mitochondria, in turn, can decrease production of high energy phosphates necessary to maintain membrane pumps and restore ionic balance in foci of axolemmal permeability change. The authors evaluated the ability of the permeability transition pore inhibitor cyclosporin A (CsA) to prevent mitochondrial swelling in injured axonal segments demonstrating altered axoAxotomy after traumatic brain injury (TBI) is not the result of overt mechanical shearing of the axon. Rather, axotomy represents the end stage of a complex process wherein the mechanical insult induces a sequence of events culminating in failure of axoplasmic transport, pooling of intra-axonal contents, and pinching off of the axon from its distal segment. Disconnection develops within hours after the traumatic episode and is termed delayed or secondary axotomy, since the primary me chanical insult provokes secondary biochemical pro-
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cesses that culminate in axotomy. This process of trau matic axonal injury (TAl) has been described in both animal models and the human clinical situation (Pov lishock and Jenkins, 1995; Adams et aI., 1982) .
The precise mechanisms responsible for this delayed! secondary axonal injury are not well characterized, but experimental studies have elucidated several focal axo nal abnormalities in TAl including altered axolemmal permeability, cytoskeletal perturbation, ionic dysregula tion, and mitochondrial alteration (Povlishock and Pet tus, 1996; Pettus and Povlishock, 1996; Gallant and Gal braith, 1997, Maxwell et aI., 1997) . In this process, it has been posited that, in the case of severe injury, the axo lemma fails first, allowing for the influx of extracellular molecules, with particular emphasis on the flux of cal cium (Ca 2 +). High intra-axonal calcium is presumed to activate Ca 2 +-dependent phosphatases and proteases and initiate the cytoskeletal collapse and mitochondrial swelling observed in injured axons (Maxwell et aI., 1997; Xiong, et aI., 1997a) .
The mitochondrial abnormalities in TAl have been associated with altered Ca 2 + compartmentalization. It has been assumed that mitochondria in foci of axolemmal failure act as Ca 2 + sinks that sequester Ca 2 + within the matrix to preserve low cytoplasmic Ca 2 + concentrations. This Ca 2 + load within the mitochondrial matrix, how ever, may lead to colloid osmotic swelling of the organ elle and collapse of organelle function (Gunter and Pfeiffer, 1990) . Local failure of mitochondria, in turn, could decrease production of high-energy phosphates necessary to maintain membrane pumps and prevent fur ther ionic imbalance in foci of axo1emmal permeability change. Thus, mitochondria may be involved in a vicious cycle whereby traumatic axolemmal perturbation leads to Ca 2 + influx, which causes mitochondrial failure and loss of energy substrate production, which, in turn, ne gates the ability of the cell to restore membrane pumps, thereby leading to further Ca 2 + entry.
Previous studies document both morphologic (swell ing, membrane blebbing) and physiologic (decreased oxidative phosphorylation, altered membrane potential) alterations associated with traumatically induced mito chondrial impairment (Colicos et aI., 1996; Xiong et aI., 1997b) . Further, we have re ported that one of the earliest markers of focal intra axonal change is mitochondrial swelling, occurring in the first minutes after injury . Also, in vitro work suggests that this mitochondrial swelling may be a factor in the development of the pathobiology of axonal injury (George et aI., 1995) .
In this process of axonal failure, previous work has focused on discerning the initiating events in axonal Ca 2 + accumulation and modulating the downstream conse quences of Ca 2 + influx in terms of protease and phos phatase activation. Yet, little consideration has been di rected toward the more intermediate events such as mi tochondrial failure and its overall influence on the fate of the injured axon. It is plausible that preservation of mi tochondrial functioning may interrupt the damaging cas cade from Ca 2 + accumulation and allow the axon to re store cation homeostasis and prevent axotomy.
Mitochondrial integrity depends on the maintenance of the membrane potential across the inner mitochondrial membrane, termed Ll'l' M (delta psi mu). Since the inner mitochondrial membrane is the seat of oxidative phos phorylation and energy production for the organelle and the cell, its potential is carefully regulated. The major regulator of Ll 'I' M under adverse conditions is the per meability transition (PT) pore, a multimeric transmem brane protein on the inner mitochondrial membrane that assembles during times of oxidative stress and Ca 2 + ac cumulation. Opening of the PT pore, loss of Ll 'I' M ' and the resultant mitochondrial permeability transition (MPT) have permanent, deleterious consequences for the organelle and the cell (Petit et aI., 1997; Ankacrona et aI., J Cereb Blood Flow Metah, Vol. 19, No.4, 1999 1995), The PT pore has regulatory sites on its cytoplas mic face that are activated by multiple effectors, notably pro-oxidants, uncoupling agents, and divalent cations (Ca 2 +). The potent immunosuppressant cyclosporin A (CsA) binds and inhibits opening of the PT pore and, thus, inhibits MPT (Zoratti and Szabo, 1995) . Cyclospor in A has been shown to prevent pore opening, MPT, and mitochondrial swelling in isolated liver and brain mito chondria exposed to high Ca 2 + concentrations (Halestrap and Davidson, 1990) .
Activation of the PT pore by Ca 2 + results in loss of Ll 'It M and colloid osmotic swelling within the mitochon drial matrix, a process that is prevented by CsA (Gunter and Pfeiffer, 1990) . Based on this information, in the current communication we evaluate the fate of mitochon dria in axonal disease. We examine the ability of the PT pore-inhibitor CsA to inhibit mitochondrial swelling af ter impact acceleration TBI in injured axons undergoing traumatically induced axolemmal change.
In addition to evaluating the potential preservation by CsA of mitochondrial morphologic features, the current communication also addresses whether this protection translates into protection for the axon itself reflected in a reduction in the number of damaged axons. To this end, antibodies to amyloid precursor protein (APP) were used, since axonal accumulations of APP are recognized as a sensitive marker of traumatically induced axonal insult (Sherriff et aI., 1994; Gentleman et aI., 1993) . We examined whether preservation of mitochondrial integ rity can limit axonal disturbances that produce accumu lations of APP.
MATERIALS AND METHODS
Electron microscopic analysis of mitochondrial status in cyclosporin A-treated and untreated injured animals Drug delivery and injury protocol. We investigated whether pretreatment with the MPT inhibitor esA could prevent mito chondrial abnormalities in axons demonstrating traumatically induced axolemmal perturbations. To identify injured axons, we examined the potential for focal axolemmal permeability change that previously has been associated with related intra axonal cytoskeletal and mitochondrial abnormality. For this purpose, we used a large molecular weight species, horseradish peroxidase (HRP), normally excluded by the intact, uninjured axolemma. After traumatically induced axolemmal change, the membrane is sufficiently disrupted to permit the local influx of HRP. Subsequent histochemical visualization of HRP specifi cally identifies this target subpopulation of injured axons.
Ten male Sprague Dawley rats (375 to 393 g) were subjected to an impact acceleration model of TBl in a manner consistent with that previously described (Marmarou et aI., 1994) . Ani mals were provided food and water ad libidum before surgery. Animals were anesthetized for 5 minutes under 4% isoflurane and a 2: 1 mixture of N 2 0: 0 2 . Rats were endotracheally intu bated and maintained under 1.5% to 2% isoflurane. Rats were secured in a stereotactic frame, and a dorsal midline neck in-cision was made over the cervical vertebrae and occiput. The atlanto-occipital membrane was exposed with blunt dissection. A 25-gauge spinal needle was stereotactically lowered into cis terna magna, and 0.1 mL of CSF was withdrawn into a 1-mL tuberculin syringe. One hour before injury, 15 mg of HRP was dissolved in the withdrawn CSF and the solution was reinfused slowly into cisterna magna. In five rats at 30 minutes before injury, 10 mg/kg of CsA (Sandoz Sandimmune Injection Prep; Novartis, Basel, Switzerland) in polyethylene glycol/sterile sa line/cremophor oil solution (250 mg CsAllO mL vehicle) was infused through the spinal needle after an equal volume of CSF (-0.12 mL) was withdrawn. These animals constituted the treatment group, CsA treated. In the other five rats, no drug was given, thereby generating the control group, untreated. The incision was sutured, and rats were removed from the stereo tactic frame.
Ten minutes before injury, parietal bones were exposed, cleaned, and dried. A steel helmet was secured in the midline between bregma and lambda with dental acrylic. Just before injury, anesthesia was withdrawn. Rats were secured on a foam bed beneath the injury tower and injured from 2 m with a 450-g weight. Thus, injury was induced 60 minutes after HRP injec tion in untreated animals, whereas in CsA-treated animals, in jury was induced 60 minutes after HRP injection and 30 min utes after CsA delivery. After injury, rats were ventilated with oxygen and monitored for recovery of respiration and reflexes.
In four of the CsA-treated animals, the femoral artery was cannulated before exposure of the atlanto-occipital membrane and blood withdrawn at specific time intervals to monitor any change in arterial blood gas parameters as a result of CsA administration. In addition, since some pharmacologic agents have been shown to exert protection through the induction of hypothermia rather than their implied mechanism of action (Buchan and Pulsinelli, 1990) , we placed a temperature probe in the temporalis muscle of two animals as a window to pos sible alterations in brain temperature resulting from CsA ad ministration.
Electron microscopic preparation. After I-hour survival time, all animals received an intraperitoneal overdose of so dium pentobarbital and were transcardially perfused with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 mollL Mil lonig's buffer. Brains were harvested and sagittally blocked to within I mm of the midline by placing the brain in a sagittal specimen holder, cutting just lateral to the pyramids, and in cluding the cervicomedullary junction. Blocked brains were postfixed overnight in the same fixative. Fifty-micrometer vi bratome sections were removed into 0.1 mollL Millonig's buffer and reacted with cobalt-glucose oxidase for HRP visu alization. Sections then were processed for light microscopic analysis to detect peroxidase-containing axonal segments. In all cases, analysis was confined to the corticospinal tract (CSpT) in the region of the pontomedullary junction, a region of known vulnerability to traumatic axonal change in this animal model (Povlishock et aI., 1997) .
Sections serially adjacent to those containing HRP-flooded axonal segments within the pontomedullary CSpT identified at the light microscopic level then were prepared for electron microscopic investigation. These sections were postfixed in 1 % OS04 in 0.1 mollL sodium phosphate buffer for 1 hour in darkness at 4°C. The sections were rinsed in 0.1 mollL sodium phosphate buffer, serially dehydrated in ascending grades of alcohols, and flat-embedded on plastic slides in medcast resin (Ted Pella). Axonal segments demonstrating HRP uptake, a marker of local axonal injury, in the plastic-embedded sections were cut out, mounted on beam capsules, and sectioned at 2 fLm on a LKB microtome. Thin sections (75 nm) were taken with a Diatome diamond knife, mounted on Formvar-coated slot grids, and stained in 5% uranyl acetate in 50% methanol and 0.5% lead citrate for electron microscopic investigation using a Zeiss EM 10CA electron microscope. Micrographs of HRP containing axons were photographed at magnifications of either 5100x or 1O,000x.
Image and statistical analysis. Sixty-two micrographs of HRP-containing CSpT axonal segments in CsA-treated injured animals and 51 micrographs of HRP-containing axonal seg ments in untreated injured animals thus were generated. Num bered micrographs were coded to blind the assessors to experi mental condition. Coded micrographs then were videographi cally captured, digitized, and enlarged on an image analysis unit (Imaging Research, St. Catherine's, Ontario, Canada) to permit quantitation of axoplasmic area, counting of total mito chondrial number, and assessment of mitochondrial integrity. Mitochondria with evidence of swelling or blebbing were scored "damaged." For this purpose, a mitochondrion was con sidered swollen if its matrix was expanded with loss of dis cernible cristae. Blebbing was considered present when one or more of the cristae were grossly expanded.
Numbered micrographs were decoded, the percentage of damaged mitochondria in axons within each group was calcu lated, and mean percent damaged mitochondria in each group (CsA-treated versus untreated) were compared with indepen dent samples t tests. Also, the total damaged mitochondrial density in axons within each group was calculated and mean density damaged mitochondria (per fLm 2 ) in each group was compared with independent samples t tests.
Amyloid precursor protein immunoreactivity in cyclosporin A-treated, untreated, and vehicle-treated injured animals
Injury protocol. Because APP immunoreactivity is widely recognized as a marker for traumatically induced axonal change (Gentleman et al., 1993) , we also explored the potential for any change in the number of APP-immunopositive axons in another sample of CsA-treated injured animals versus untreated and vehicle-treated injured animals.
In this case, 12 additional male Sprague Dawley rats (375 to 400 g) were anesthetized, intubated, and secured in a stereo tactic frame as described earlier. Animals were provided food and water ad lihidum before surgery. A dorsal midline neck incision was made over the cervical vertebrae and occiput, and the atlanto-occipital membrane was exposed with blunt dissec tion. In four of the animals, 30 minutes before injury, a 25-gauge spinal needle was stereotactically lowered to tap cisterna magna, and 10 mg/kg of CsA in polyethylene glycol/cremophor oil (25 mg/mL of solution) solution were infused through the spinal needle after an equal volume of CSF was withdrawn. In the four vehicle-treated animals, 0.12 mL of CSF was with drawn and an equal volume of polyethylene glycol/sterile sa line/cremophor oil vehicle was infused. In the four untreated animals, 0.12 mL CSF was withdrawn and reinfused.
Ten minutes before injury, parietal bones were exposed, cleaned, and dried. A steel helmet was secured midway be tween bregma and lambda with dental acrylic, and the animals were injured in a manner consistent with that described earlier.
Immunohistochemistry. In all 12 cases, after 24 hours of survival, rats were administered an intraperitoneal overdose of sodium pentobarbital and transcardially perfused with 4% para formaldehyde and 0.1 % glutaraldehyde in 0.1 mollL Millonig' s buffer. Brains were harvested, sagittally blocked just lateral to the pyramids (consistent with the methods previously described for our mitochondrial studies), and postfixed overnight in the For image analysis of the CsA-treated, untreated, and vehicle-treated cases, slides were examined with an Olympus BH-2 microscope at lOx, and areas of high-density APP immunoreactivity within the CSpT were videographically captured and digitized. Scanning was re stricted in all cases to the CSpT in the region of the pontomed ullary junction, a known vulnerable site to traumatic axonal change . The digitized images were imported into an image analysis unit (Imaging Research, St. Catherine's, Ontario, Canada), and the area of the CSpT captured was measured. Total number of APP-positive axons greater than 1 0 �m in diameter within this area were marked, counted, and expressed as density of APP-positive axons per unit area. Investigators were blinded in the data analysis of the CsA-treated and untreated cases.
Mean densities of APP-immunopositive CSpT axons were compared among CsA-treated, untreated, and vehicle-treated injured animals with a one-way analysis of variance (ANOV A) statistical test.
RESULTS

Physiologic response to cyclosporin A administration and injury
CsA administration did not produce physiologically significant changes in arterial blood gas parameters (Table 1) . Temporalis temperature monitoring indicated that CsA administration produced a slight reduction in brain temperature from 37.5° to 36.5°C over 1 hour after injection. Brain temperature returned to baseline within 90 minutes of administration. Such a decline in brain temperature, however, is not consistent with temperature ranges necessary for any therapeutic effect of hypother mia (Buchan and Pulsinelli, 1990) . 
T reatment Group
swollen or "blown-out" mitochondria ( Fig. I) , whereas HRP-containing axonal segments from CsA-treated in jured animals had significantly fewer swollen mitochon dria (Fig. 2) . The mean percentage of damaged mito chondria in HRP-containing axons of untreated animals was 71.94 ± 31 % (mean ± SD (N = 52), whereas mean percentage of damaged mitochondria in HRP-containing axonal segments of CsA-treated animals was 27.96 ± 16% (N = 61). Independent samples t test revealed a significant difference between the groups with P < 0.001 (Fig. 3A) . Furthermore, the density of damaged mito chondria in HRP-containing axonal segments in CsA treated injured animals (0.107 ± 0.11lf.lm 2 of axoplasm) was significantly less than the density of damaged mito chondria in HRP-containing axonal segments harvested from untreated animals (0.304 ± 0.38/f.lm 2 ) (Fig. 3B) . Damaged mitochondria per unit area were statistically lower in CsA-treated injured animals at P < 0.001.
Preservation of axonal integrity in cyclosporin A-treated animals
A single bolus of CsA before injury also significantly protected against delayed axotomy after impact accelera tion injury. Digitized fields of CSpT in untreated animals showed larger numbers of APP-immunopositive axons when compared with similar fields from CsA-treated ani mals (Fig. 4) . Mean density of APP-immunoreactive axons in CsA-treated injured animals was 247.40 ± 1611 mm 2 (N = 20), whereas mean density of APP immunoreactive axons in untreated injured animals was 388.43 ± 65/mm 2 (N = 20) (Fig. 5) . The difference in means was significant at P < 0.001 (one-way ANOV A).
Vehicle infusion had no effect on the progression to delayed axotomy after impact acceleration injury. Mean density of APP-immunoreactive axons in CSpT of ve hicle-treated animals was 427.09 ± 88/mm 2 (N = 20), which was significantly higher than mean density in CsA-treated animals (P < 0.0001, one-way ANOVA). Importantly, no difference was noted between mean den sity of APP-positive profiles in untreated control versus vehicle-treated animals (P > 0.1, one-way ANOV A). jured and axotomized axons. These findings represent the first direct evidence of in vivo pharmacologic pres ervation of mitochondrial morphologic features in TBI and provide intriguing insight into the role of mitochon dria in the pathogenesis of TAL Furthermore, these re sults intimate that interruption of secondary injury pro cesses provides protection to the axon. The key question in this process, then, centers on how CsA protects mitochondria in injured axons and how this translates into protection for the axon itself. As observed earlier, CsA is known to block the Ca 2 +-induced collapse of mitochondrial respiration by inhibiting opening of the PT pore, the main route through which Ca 2 + crosses the inner mitochondrial membrane under conditions of oxi dative stress (Zoratti and Szabo, 1995; Gunter and Pfeiffer, 1990) . The mechanism of action of CsA is de pendent on binding to its partner molecule cyclophilin, a member of the immunophilin family of proteins, which are present in the mitochondrial matrix and cytosol (Chadhuri and Stephan, 1995) . Under conditions of oxi dative stress (high Ca 2 +, low ATP, high Pi), cyclophilins can induce a conformational change in the PT pore that allows nonspecific passage of solutes less than 1.5 kd (Halestrap and, 1990; Halestrap et aI., 1997) . Binding by CsA prevents cyclophilin from interacting with the PT pore complex.
Additionally, CsA-cyclophilin complexes within the cytosol have other targets including calcineurin, a Ca 2 + dependent and calmodulin-dependent serine/threonine phosphatase (Liu et aI., 199 I) . Calcineurin inhibition is believed to be the primary target mediating the main historical on-label use of cyclosporin as a potent immu nosuppressant. In lymphocytes, calcineurin dephos phorylates a transcription factor, nuclear factor of acti vated T cells, thereby decreasing interleukin-2 secretion in antigen-reactive T cells and, thus, T-cell proliferation (Schreiber and Crabtree, 1992) .
Whereas the implications for calcineurin inhibition in neurons and in neurotrauma are unclear, the discovery that the immunophilins are expressed in high concentra tions in the brain (Steiner et aI., 1992; Dawson et aI., 1994) led to numerous investigations of the possible neu ral roles for immunophilins. Immunophilin-immunosup pressant complexes have been implicated in regulation of IP-3-regulated Ca 2 + release, nitric oxide-stimulated glu tamate release, neurite outgrowth, kindling, hippocampal long-term potentiation, and a host of other processes oc curring in both normal and diseased brain (see Sabatini et aI., 1997; Gold 1997) .
Based on this, it is clear that although the role of calcineurin inhibition is uncertain, CsA-mediated block ade of the PT pore could preserve the supply of energy substrates in injured axons by limiting the extent of mi tochondrial damage. Evidence to support this premise derives from multiple sources. In the field of ischemia, there is evidence to support a role for mitochondria in mediating axonal failure as well as evidence for neuro protection by CsA (Siesjo and Siesjo, 1996) . Such stud ies in ischemia also have pointed to the failure of mem brane pumps and loss of ionic homeostasis in the devel opment of axonopathy and to the mitochondrial mediation of axonal failure (LoPachin and Stys, 1995; Stys et aI., 1992; Waxman et aI., 1992; Waxman et aI., 1994) . In this process, it has been posited that the axo lemma first fails, allowing for membrane depolarization and the ultimate axoplasmic accumulation of Ca 2 + through reverse operation of the Na+-Ca 2 + exchanger (LoPachin and Lehning, 1997). High axonal Ca 2 + in duces mitochondrial swelling and initiates Ca 2 + -sensitive enzymes (proteases, phospholipases, endonucleases), which cause a procession toward irreversible axonal de generation (Duchen et aI., 1993) . Interestingly, Ca 2 + ac cumulation within mitochondria precedes subsequent ac cumulation of Ca 2 + within the axoplasm, and this mito chondrial failure contributes to the deficit of energy substrates in these failing neurons (LoPachin and Lehn ing, 1997) . This has led some to contend that mitochon dria may be the key determinants of the irreversibility of axonal insult (Duchen et aI., 1993; LoPachin and Lehn ing, 1997) .
Although this is the first report of CsA neuroprotec tion in TBI, several groups have reported preservation of the bioenergetic state of mitochondria and increased sur vival of ischemic hippocampal neurons after CsA admin istration (Uchino et aI., 1995; Li et aI., 1997; Shiga et aI., 1992; Folbergrova et aI., 1997; Dawson et aI., 1993; Steiner et aI., 1996 , Balakirev, et aI., 1997 . These stud ies report lower incidences of delayed hippocampal cell death and smaller areas of cerebral infarction after CsA, and all point to mitochondrial protection as the common mediator of protection. Collectively, their data speak to the ability of CsA to limit ischemic neurotoxicity through direct and indirect inhibition of MPT. In contrast to the current communication, however, these studies of ischemia used relatively gross measures of neuronal cell survival and triphenyl tetrazolium chloride staining to speculate on the protective effects of CsA administration. Our work, on the other hand, directly assesses the ultra stru ctural fate of mitochondria after CsA treatment, in addition to evaluating its effects on the total number of damaged axons. Thus, our results define the site of pro tection as the mitochondria themselves rather than only addressing the more global issue of cell or axonal sur vival.
Our results indicate that, in foci of axonal perturbation in CsA-treated injured animals, roughly three fourths of mitochondria are morphologically intact and, ostensibly, functioning, whereas one fourth undergo an MPT and swell. Perhaps bioenergetic failure of mitochondria di minishes the axon's ability to restore ionic homeostasis.
Thus, maintenance of oxidative respiration and ATP sup ply from the functioning three fourths of mitochondria may permit the continued functioning of ATP-dependent membrane pumps, thereby limiting enduring changes in ionic imbalance. A MPT in the swollen one fourth of mitochondria with consequent Ca 2 + accumulation in the matrix could protect the axoplasm from the damaging effects of a large Ca 2 + load. This would create a condu cive environment for recovery of the injured axon: con tinued ATP supply and low axoplasmic Ca 2 +.
A physiologic role of MPT has been proposed whereby a MPT would create large Ca 2 + sinks in the matrix that could release Ca 2 + later, while still permitting recovery of that mitochondrion. In this scenario, A TP production from the organelle would temporarily cease, but the cytoplasm would be protected from Ca 2 + over load. The subsequent recovery from a massive Ca 2 + in flux into the matrix across permeabilized mitochondrial membranes would require less energy than to have ex truded the same load of Ca 2 + using membrane pumps. Given the in vivo reversibility of MPT, such a proposal would represent a highly cost-effective protection mechanism for the cell.
Moving on the premise of CsA neuroprotection in TAl, other questions remain concerning the efficacy of CsA if administered in a delayed treatment paradigm or if given through other routes of administration. In the studies reported here, CsA was administered 30 minutes before injury. Therefore, the potential therapeutic ben efits of delayed administration must await further study. Also, since the intrathecal administration route used in the current study is not an optimal route of administra tion, the efficacy of CsA through systemic routes also remains to be explored. These issues are confounded by the fact that CsA does not cross the blood-brain barrier in appreciable quantities (Begley et aI., 1990) . However, it is known that TBI transiently alters blood-brain barrier properties, so that CsA access to the brain parenchyma across the vascular border may be possible (Povlishock et aI., 1978) .
Possible criticisms of the current findings could arise on two fronts: first, whether the applied intrathecal CsA actually reached the target sites under evaluation, and, secondly, if the observed axonal protection translated into improved behavioral outcome in the rat. Although because of technical limitations we were unable to ra diolabel CsA, our experience using intrathecal tracers strongly argues that the agent did reach the target sites. As we have both in this and past studies demonstrated that intrathecal injection of HRP (44,000 molecular weight [MW] ) successfully delivers this macromolecule to known vulnerable sites within the neuraxis Povlishock and Pettus, 1996) , there is no compelling argument to dismiss a similar level of access for CsA, which is only a 1203-MW polypeptide.
J Cereb Blood Flow Metab, Vol. 19, No. 4, 1999 Whether CsA improves behavioral outcome after TBI related to the fibers under investigation is an issue of importance in our laboratory, Motor outcome, however, is difficult to assess directly because in animals, as in humans, motor deficits after TBI exhibit spontaneous recovery. Thus, experimental strategies to assess motor recovery have poor sensitivity. Parallel investigations in our laboratory were conducted to examine motor recov ery using the same drug delivery protocol and doses as the studies reported here. Unfortunately, no beneficial effect of a single pretreatment with CsA was detected, We believe that this most likely resulted from the spon taneous recovery of motor function, which limited our ability to detect therapeutic efficacy given the small population of inured axons.
These results provide clear evidence that mitochondria are important mediators in the development of TAL The literature supports that CsA both induces a favorable Ca 2 + compartmentalization within the axon and pre serves the bioenergetic state of mitochondria, Mediation of mitochondrial functioning in injured foci by CsA has positive effects on the outcome of the traumatically in jured axon and thus may have long-range therapeutic implications for use in brain-injured humans.
